Erlotinib Hydrochloride in Preventing Cancer in Patients With Precancerous Lesions of the Lung

This study has been terminated.
Sponsor:
Information provided by (Responsible Party):
National Cancer Institute (NCI)
ClinicalTrials.gov Identifier:
NCT01013831
First received: November 13, 2009
Last updated: February 17, 2015
Last verified: April 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: June 2013
  Primary Completion Date: February 2012 (Final data collection date for primary outcome measure)